Health And Wellness News: FDA Enforcement Discretion On Allulose Labeling, More
FDA extends sunscreen proposed rule comment period; American Kratom Association AKA webinar counters ‘incorrect’ headlines; ProBiora promotes brand with comic book; and Allulose labeling draft guidance includes enforcement discretion.
You may also be interested in...
As in previous warnings to kratom supplement marketers linked to opioid addiction treatment claims, FDA tells Cali Botanicals and Kratom NC that HHS in 2017 found opioid abuse was nationwide public health emergency and FDA is targeting products that without approval claim to diagnose, mitigate, prevent, treat or cure opioid addiction. Contract manufacturer Somlabs' GMP problems also were identified in FDA's latest warning letters.
FDA seeks injunction against Confidence USA; Crown Labs expands again; CHPA, PCPC say Environmental Working Group "irresponsibly misrepresents” evidence on sunscreen safety; Kratom Information & Resource Center says 92% of news about kratom published since February was ‘unfair and unbalanced’; more news.
Georgia, Utah age-restrict kratom product sales and set labeling requirements. American Kratom Association says states' actions and its recently adopted GMP standards should help weed out bad actors, but FDA says lab testing found high levels of heavy metals in kratom supplements.